The notices it replaced
- Reissues: PA-13-088 PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 2 steps back: PA-12-088 PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 3 steps back: PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 4 steps back: PA-10-050 PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 5 steps back: PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Replaced by PA-14-071.
Who won it before
633 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $215,135,443 in first-year total cost, median $224,915.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-G (12)]43
- Special Emphasis Panel[ZRG1 ETTN-M (11)]35
- Special Emphasis Panel[ZRG1 IMST-L (11)]30
- Special Emphasis Panel[ZRG1 IMST-S (12)]27
- Special Emphasis Panel[ZRG1 SBIB-T (10)]27
Most frequent institutions
- PANORAMA RESEARCH, INC.9
- AFFINERGY, LLC7
- PHYSICAL SCIENCES, INC7
- PROGENRA, INC.7
- P2D, INC.5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | eClinic: An Innovative Technology for Clinical Laboratory Sciences Education2R44TR000033-02 | BOLDUC, ELROY J. | ATHENA GROUP, INC., FL | $499,060 | ZRG1 |
| 2015 | Novel Use of Emergent Technologies to Improve Efficiency of Animal Model Research1R43GM112206-01 | DONNELLY, CHARLES J | ROCKSTEP SOLUTIONS, INC., ME | $224,870 | ZRG1 |
| 2015 | Promoting Best Practices through Capacity Building for ART Adherence in HIV Care1R43AI114383-01 | CARD, JOSEFINA JAYME | SOCIOMETRICS CORPORATION, CA | $150,000 | ZRG1 |
| 2014 | Gene Based Therapy for Congestive Heart Failure P2 SBIR2R44HL108581-02A1 | MCINTYRE, MARITZA C | NANOCOR THERAPEUTICS, INC., NC | $2,623,563 | ZRG1 |
| 2014 | Miniature Stimulator for Temporary Therapies2R44HD067094-04 | BENNETT, MARIA | SPR THERAPEUTICS, LLC, OH | $1,533,917 | MRS |
| 2014 | A potassium-ATP channel opener for prevention of contrast-induced nephropathy2R44DK091972-02 | SALZMAN, ANDREW LURIE | RADIKAL THERAPEUTICS, INC., MA | $1,527,261 | ZRG1 |
| 2014 | Preclinical development of ONL-101 for photoreceptor protection in retinal detach2R44EY022512-02A1 | JOHNSON, LINDA LEA | ONL THERAPEUTICS, INC., MI | $1,372,371 | ZRG1 |
| 2014 | Synthetic microparticle malaria vaccine2R44AI091089-03A1 · under PA-13-088 | POWELL, THOMAS J | ARTIFICIAL CELL TECHNOLOGIES, INC., CT | $1,372,308 | ZRG1 |
| 2014 | Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies2R44AI100753-02 · under PA-13-088 | LAGENAUR, LAUREL A. | OSEL, INC., CA | $1,335,502 | ADDT |
| 2014 | Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation2R44DK092041-02A1 · under PA-13-088 | FRANK, BRUCE HILL | THERMALIN DIABETES, LLC, OH | $1,275,297 | ZRG1 |
| 2014 | Rotating PET and linear accelerator system for PET-guided radiation therapy2R44CA153466-02A1 · under PA-13-088 | MAZIN, SAMUEL | REFLEXION MEDICAL, INC., CA | $1,169,548 | ZRG1 |
| 2014 | Augmented Reality System to Teach Hemostatic Agent Use in Hemorrhage Control2R44GM100522-02 · under PA-13-088 | NOVOTNY, PAUL | SIMQUEST INTERNATIONAL, LLC, MD | $1,087,913 | ZRG1 |
| 2014 | Development of a drug discovery platform for human islets2R44DK093392-02 · under PA-13-088 | BUEHRER, BENJAMIN M | ZEN-BIO, INC., NC | $1,072,731 | ZRG1 |
| 2014 | Health in Motion- Interactive Exercises for Safer Mobility2R44AG043191-02 | FLYNN, SHERYL | BLUE MARBLE REHAB, INC., CA | $1,071,755 | ZRG1 |
| 2014 | Development of a High Performance Bioprocess for Eliminating 1,4-Dioxane in Water2R44ES022123-02 · under PA-13-088 | SALANITRO, JOSEPH | MICROVI BIOTECH, INC., CA | $1,068,546 | ZRG1 |
| 2014 | Extending Genome-Phenome Analysis2R42HG006974-02 | SEGAL, MICHAEL M | SIMULCONSULT, INC., MA | $1,052,394 | ZRG1 |
| 2014 | Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive2R44DK085766-04 · under PA-13-088 | CHARYTAN, DAVID MTILLES, ARNO W | SENTIEN BIOTECHNOLOGIES, INC., MA | $1,016,886 | ZRG1 |
| 2014 | Nanoparticle-based Sensitizer for Radiation Therapy of Glioblastoma2R44CA144817-02A1 | BROWN, JOHN MARTINSCHECK, ADRIENNE CUNGER, EVAN CHARLES | NUVOX PHARMA, LLC, AZ | $1,000,000 | ZRG1 |
| 2014 | Novel Single Well Avidity EIA to Determine Recency of HIV-1 Infections2R44AI097001-02A1 | MINK, RONALD WILLIAM | SEDIA BIOSCIENCES CORPORATION, OR | $1,000,000 | ZRG1 |
| 2014 | Clinical Evaluation of a Long Term Implanted Glucose Sensor2R44DK077254-06 · under PA-13-088 | LUCISANO, JOSEPH Y. | GLYSENS, INC., CA | $999,876 | ZRG1 |
| 2014 | Portable Gas Perfusion System for Pancreas Preservation2R44DK070400-05A1 | PAPAS, KLEARCHOS KTEMPELMAN, LINDA A | GINER, INC., MA | $999,784 | ZRG1 |
| 2014 | Dendritic Cell-Targeted HIV Vaccine Product2R44AI095159-02A1 · under PA-13-088 | KELER, TIBOR | CELLDEX THERAPEUTICS, INC., NJ | $999,540 | VACC |
| 2014 | Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds2R44DK080567-04A1 · under PA-13-088 | GHATNEKAR, GAUTAM SUDHIR | XEQUEL BIO, INC., SC | $999,289 | ZRG1 |
| 2014 | Sensitive Measurement of Cardiac Troponin I at Point of Care: The Silicon BioDevi2R44HL116078-02 · under PA-13-088 | FLORESCU, OCTAVIAN | SILICON BIODEVICES, INC., CA | $993,000 | ZRG1 |
| 2014 | An intervention to improve adolescent headache self-management2R44HD066920-03A1 | TRUDEAU, KIMBERLEE JEANTSAO, JENNIE C | INFLEXXION, INC., MA | $989,919 | ZRG1 |
| 2014 | Preventing asthma exacerbations by reducing viral respiratory infections2R44HL115903-02 | SCOTT, BRENTON | PULMOTECT, INC, TX | $985,628 | ZRG1 |
| 2014 | An Implantable Intraocular Pressure Control System - Phase II2R44EY014284-02A1 | DELAHANTY, THOMAS C | FORSYTHE TECHNOLOGIES WORLDWIDE, INC., CA | $966,681 | ZRG1 |
| 2014 | Expanding small molecule functional metagenomics through shuttle BAC expression i2R44AI094885-02 | BOK, JIN WOOKELLEHER, NEIL LWU, CHENGCANG CHARLES | INTACT GENOMICS, INC., MO | $941,322 | ZRG1 |
| 2014 | Computer assisted clinical decision support tool for management of statins2R44HL117553-02 | HUTCHERSON, STEPHEN | ALGORITHMRX, LLC, VA | $910,888 | ZRG1 |
| 2014 | Novel therapeutics for fatty liver disease and type-II diabetes2R44DK093345-02 · under PA-13-088 | MUSSO, DAVENIEROBISZ, LIDIAYI, NA YOUNG | SOUTHEAST TECHINVENTURES, INC., NC | $909,785 | ZRG1 |
| 2014 | Plasmodium Genus and PFV Fluorescent In Situ Hybridization (FISH) Assay Kit for d2R44AI056785-04 · under PA-13-088 | SHAH, JYOTSNA S | ID FISH TECHNOLOGY, INC., CA | $885,321 | ZRG1 |
| 2014 | A molecular barcoding sequencing kit for highly efficient and accurate single cel2R44HG007130-02 | FU, GLENN | CELLULAR RESEARCH, INC., CA | $866,200 | ZRG1 |
| 2014 | Selective Fyn kinase inhibitors for treatment of metabolic disease2R44DK093387-02A1 | BUEHRER, BENJAMIN M | ZEN-BIO, INC., NC | $855,351 | ZRG1 |
| 2014 | Novel Treatments to Abolish Inflammatory Mediators in Hemodialysis2R44DK082025-02A1 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $849,661 | ZRG1 |
| 2014 | Hemorrhage Control During Brain Surgery2R44NS070331-02A1 | CHEN, WEILIAM | ENDOMEDIX, INC., NJ | $842,322 | ZRG1 |
| 2014 | Sustained Release Inner Ear Delivery of Corticosteroid2R44DC008477-04A1 | PIERSTORFF, ERIKSLATTERY, WILLIAM H | O-RAY PHARMA, INC., CA | $839,147 | ZRG1 |
| 2014 | Automated Ultrasensitive Detection of Light Chain Restriction in Lymphoproliferat2R44CA168019-02A1 | MA, XIAO-JUN | ADVANCED CELL DIAGNOSTICS, INC., CA | $834,236 | ZRG1 |
| 2014 | Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens2R44AI096598-02 | LEDIZET, MICHEL | L2 DIAGNOSTICS, LLC, CT | $829,432 | ZRG1 |
| 2014 | Active Fine Gauge Spinal Needle with CSF Sensing to Minimize PDPH and Dura Damage2R44GM100535-02 | MULVIHILL, MAUREEN L. | ACTUATED MEDICAL, INC., PA | $826,824 | ZRG1 |
| 2014 | The Development of RORgt Immunomodulators Targeting the TH17 Axis in IBD- Phase 22R44DK098896-02 | ALTON, GORDONZAPF, JIM | VISIONARY PHARMACEUTICALS, INC., CA | $824,726 | ZRG1 |
| 2014 | Development and Commercialization of Nanostructured Resorbable Urogenital Grafts2R44CA136033-02 · under PA-13-088 | YAO, CHANG | NANOVIS, LLC, IN | $822,303 | ZRG1 |
| 2014 | Development of a Porcine Model of Duchenne Muscular Dystrophy2R44AR061900-02A1 · under PA-13-088 | ROGERS, CHRISTOPHER | EXEMPLAR GENETICS, LLC, IA | $814,243 | ZRG1 |
| 2014 | A High Performance Point-of-Care Device for Umbilical Cord Blood Processing2R44OD016688-02 | HUANG, LOTIEN RICHARD | CYTOVERA, INC., MA | $810,130 | ZRG1 |
| 2014 | Bioengineered Recombinant FVIII2R44HL117511-02 · under PA-13-088 | DENNING, GABRIELADOERING, CHRISTOPHER BRADLEYLOLLAR, JOHN S. | EXPRESSION THERAPEUTICS, GA | $809,918 | ZRG1 |
| 2014 | Diffusion Weighted Breast MR Imaging for Screening Women with Dense Breasts2R44CA186313-02 | PENN, ALAN I. | ALAN PENN AND ASSOCIATES, INC., MD | $798,404 | ZRG1 |
| 2014 | Low-cost handheld medical device for neuroaxial anesthesia guidance in the obese2R44EB015232-02 | MAULDIN, FRANK WILLIAM | RIVANNA MEDICAL, INC., VA | $797,265 | ZRG1 |
| 2014 | Deep Letter Knowledge for Emerging Literacy2R44HD072651-02 | HERRON, JEANNINE | TALKING FINGERS, INC., CA | $787,765 | ZRG1 |
| 2014 | Virtual Occupational Therapy Assistant (VOTA)2R44HD071745-02 | ADAMS, RICHARD J. | BARRON ASSOCIATES, INC., VA | $787,194 | ZRG1 |
| 2014 | Development of a Field-Deployable Device to Rapidly Measure Blood Cyanide Levels2R44NS076359-02A1 | BOEHRINGER, HANS | DIAGNOSTIC CONSULTING NETWORK, INC., CA | $784,242 | ZRG1 |
| 2014 | A Patient-Driven Rehabilitation System to Improve Upper Limb Amputee Outcomes2R44HD072668-02 | KALIKI, RAHUL REDDYMIGUELEZ, JOHN MTHAKOR, NITISH VYOMESH | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $777,926 | ZRG1 |
| 2014 | Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric2R44HD074326-02 | DORMER, NATHAN H | ORBIS BIOSCIENCES, INC., KS | $775,511 | ZRG1 |
| 2014 | Antibacterial molecular coatings pre-fabricated for biologic wound dressings2R44AR061913-02A1 · under PA-13-088 | AGARWAL, ANKIT | IMBED BIOSCIENCES, INC., WI | $775,221 | ZRG1 |
| 2014 | Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test2R44HL107040-03 | NEUMANN, THOMAS | NORTIS, INC., WA | $770,090 | ZRG1 |
| 2014 | Adjustable Helmet Array for Neonatal Magnetoencephalography2R44HD074495-02 · under PA-13-088 | SHAH, VISHAL K | QUSPIN, CO | $761,923 | ZRG1 |
| 2014 | Preclinical testing of the splice modulating oligonucleotide LSP-GR12R44NS076194-03A1 · under PA-13-088 | LUTZ, GORDON J | LIFESPLICE PHARMA, LLC, PA | $759,114 | ZRG1 |
| 2014 | PRECLINICAL DEVELOPMENT OF NOVEL SMOKING CESSATION PHARMACOTHERAPIES2R44DA033744-02 | ZAVERI, NURULAIN T | ASTRAEA THERAPEUTICS, LLC, CA | $757,870 | ZRG1 |
| 2014 | IntelliWheels: The Automatic Transmission for Manually Propelled Wheelchairs2R44HD071653-02 | DAIGLE, SCOTT CHRISTOPHER | INTELLIWHEELS, INC., IL | $757,333 | MRS |
| 2014 | A device for rapid, painless, bedside muscle evaluation of children with neuromus2R44NS073188-03 · under PA-13-088 | BOHORQUEZ, JOSE LUISZAIDMAN, CRAIG MITCHELL | MYOLEX, INC., MA | $755,700 | ZRG1 |
| 2014 | PET Enabled Microspheres for Radioembolization of Liver Tumors2R44CA165898-02 | PENG, YONGREN BENJAMIN | XL SCI-TECH, INC., WA | $755,535 | ZRG1 |
| 2014 | IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma2R44CA167925-02 | WONG, HING C. | ALTOR BIOSCIENCE. LLC, FL | $750,000 | ZRG1 |
| 2014 | A Novel Therapeutic for Invasive Candidiasis2R44AI106270-04A1 | DIAMOND, GILLSCOTT, RICHARD W | FOX CHASE CHEMICAL DIVERSITY CENTER, INC, PA | $750,000 | ZRG1 |
| 2014 | Development of a Small Molecule Inhibitor for EBV Latent Infection2R44AI096588-03 | LIEBERMAN, PAUL M.VAN DEN HEUVEL, PIETER | VIRONIKA, LLC, PA | $750,000 | ZRG1 |
| 2014 | A Computer Modeling Approach2R44NS079204-03A1 | MUTZ, MITCHELL W | AMPLYX PHARMACEUTICALS, INC., CA | $749,999 | ADDT |
| 2014 | Technology Application to Enhance Discharge Referral Decision Support2R44NR013609-02 | HEIL, ERIC | RIGHTCARE SOLUTIONS, INC., PA | $749,637 | ZRG1 |
| 2014 | Low Cost Modular Tissue Microarray Instrument2R44CA183447-02 · under PA-13-088 | JAGIELSKI, MICHAEL T | MICATU, INC., NY | $749,243 | ZRG1 |
| 2014 | Optical Surgical Probe for Assessing Human Oral Mucosa Graft Vascularization2R44DE021935-02 | CHRISTIAN, JAMES F | RADIATION MONITORING DEVICES, INC., MA | $749,134 | ZRG1 |
| 2014 | Therapy and Prophylaxis for Genital Tract Infection2R44AI104067-02 | AUCI, DOMINICK LLIU, YINGRU | THERAPYX, INC., NY | $749,000 | ZRG1 |
| 2014 | A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma2R44CA159843-02 | BALHORN, RODNEY | SHAL TECHNOLOGIES, INC., CA | $748,921 | ZRG1 |
| 2014 | Transcutaneous Energy Transmission System for Fully Implantable VADs2R44HL108415-02 · under PA-13-088 | MCCABE, AARON RICHARDWEISS, WILLIAM J | MINNETRONIX, INC., MN | $748,797 | ZRG1 |
| 2014 | A Combination Therapy Approach to Treating Drug Resistant Fungal Infections2R44AI096844-02A1 | MUTZ, MITCHELL W | AMPLYX PHARMACEUTICALS, INC., CA | $748,540 | ZRG1 |
| 2014 | A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications2R44AG039139-02A1 · under PA-13-088 | LICHTER, PATRICK | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $747,784 | ZRG1 |
| 2014 | SAMBA HIV-1 Semi-quantitative Test for resource limited settings2R44AI097120-03A1 · under PA-13-088 | LEE, HELEN H | DIAGNOSTICS FOR THE REAL WORLD, LTD, CA | $747,488 | ZRG1 |
| 2014 | Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr2R44AR063509-02 | OSTANIN, KIRILL | NAVIGEN, INC., UT | $747,226 | ZRG1 |
| 2014 | Structural bioinformatics software for epitope selection and antibody engineering2R44GM100520-02 | DARNELL, STEVEN JOSEPH | DNASTAR, INC., WI | $746,428 | ZRG1 |
| 2014 | Injectable microgel for soft tissue repair2R44GM108070-02 | SALAMONE, JOSEPH C. | ROCHAL INDUSTRIES, LLP, TX | $742,307 | ZRG1 |
| 2014 | Multiplexed Nucleic Acid Assays2R44GM096706-03 · under PA-13-088 | CHEE, MARK S. | PROGNOSYS BIOSCIENCES, INC., CA | $739,061 | ZRG1 |
| 2014 | Salivary-Based Bone-Loss Marker Detection Platform for Point-of-Care Screening2R44DE022478-02 | BESHAY, MANAL | INTELLIGENT OPTICAL SYSTEMS, INC., CA | $737,794 | ZRG1 |
| 2014 | Nonthrombogenic, Antiseptic Nitric Oxide Releasing Catheters2R44HL114148-02 | MERZ, SCOTT I | MC3, INC., MI | $735,508 | ZRG1 |
| 2014 | Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain2R44AI094823-02 | BLATTNER, FREDERICK RLANDRY, CHARLES F | SCARAB GENOMICS, LLC, WI | $732,955 | ZRG1 |
| 2014 | PSA Peptidase Activity (PPA): A New Biomarker for Prostate Cancer Aggressiveness2R44CA156786-02A1 | LAI, FANG | OHMX CORPORATION, IL | $724,554 | ZRG1 |
| 2014 | Accelerating Wound Healing through RNAi2R44GM101725-02 | JOHNSTON, BRIAN H. | SOMAGENICS, INC., CA | $723,483 | ZRG1 |
| 2014 | Ubiquitin E3 ligase detection by fluorescence resonance transfer2R44GM097827-02 · under PA-13-088 | STERNER, DAVID E | PROGENRA, INC., PA | $723,331 | ZRG1 |
| 2014 | Refinement of an autodissemination station for control of mosquito vectors2R44AI096563-02A1 · under PA-13-088 | BANFIELD, MICHAEL GILBERTWANG, YI | BANFIELDBIO INC., WA | $722,493 | ZRG1 |
| 2014 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing2R44AR062418-02 | JACKSON, WESLEY MICHAEL | VALITOR, INC., CA | $716,719 | ZRG1 |
| 2014 | Electrode Arrays for Bloodless Liver Resection and Tumor Ablation2R44CA126312-02A1 | SCHMIDT, RICHARDSHANMUGANAYAGAM, DHANANSAYANWILL, JAMES ARTHUR | MEDICAL ENGINEERING INNOVATIONS, LLC, WI | $716,252 | ZRG1 |
| 2014 | Continuous Chromatography Device to Economically Purify Clinical-grade Antibodies2R44CA162632-02 | MIERENDORF, ROBERT C | SEMBA BIOSCIENCES, INC., WI | $711,327 | ZRG1 |
| 2014 | Multiplex cell-based platform for kinase drug discovery2R44CA168209-02 | KRUTZIK, PETER | PRIMITY, INC., CA | $706,212 | ZRG1 |
| 2014 | Peptide-coated skin substitutes for the treatment of burn injuries and wounds2R44GM101759-02A1 | LAMB, BRUCE | AFFINERGY, LLC, NC | $695,448 | ZRG1 |
| 2014 | Cloud computing platform for virtual screening and drug discovery.2R44GM097902-02A1 · under PA-13-088 | DOCKHORN, ROBERT J | B-TECH CONSULTING, LTD, PA | $681,314 | ZRG1 |
| 2014 | Development of Selective Inhibitors of NaV1.7 as Therapeutics for Pain2R44NS081887-02 | MILJANICH, GEORGEMULCAHY, JOHN VINCENT | SITEONE THERAPEUTICS, INC., CA | $681,135 | ZRG1 |
| 2014 | Air Barrier System for the Prevention of Prosthesis-related Infections2R44GM095005-05 | DAROUICHE, RABIH OSELF, SEAN | NIMBIC SYSTEMS, INC., TX | $670,055 | ZRG1 |
| 2014 | Multifunctional nanoformulations for diagnostic imaging of atherosclerosis2R44HL110417-02 | SIGALOV, ALEXANDER B | SIGNABLOK, INC., MA | $669,647 | ZRG1 |
| 2014 | Novel molecular therapeutics for cystic fibrosis2R44HL114299-02 | STERNER, DAVID E | PROGENRA, INC., PA | $668,380 | ZRG1 |
| 2014 | Polaris EECD: Improving Patient Engagement in Chemically Dependent Adults- Phase2R44DA032180-02 | GRISSOM, GRANT R | POLARIS HEALTH DIRECTIONS, INC., PA | $665,859 | ZRG1 |
| 2014 | A NEW MECHANISM FOR TREATING OBESITY2R44HL112484-02 | WAKIL, SALIH J | FGH BIOTECH, INC., TX | $665,607 | ZRG1 |
| 2014 | Bioengineered factor VIII gene therapy for hemophilia A2R44HL114241-02A1 | DENNING, GABRIELADOERING, CHRISTOPHER BRADLEYSPENCER, H TRENT | EXPRESSION THERAPEUTICS, GA | $659,086 | ZRG1 |
| 2014 | Molecular Kits and Software for Lymphoid Malignancy Work-ups2R44CA171469-02 · under PA-13-088 | JOHNSON, DAVID SCOTT | GIGAGEN, INC., CA | $656,240 | ZRG1 |
| 2014 | Padres Preparados: An Evidence-Based Parenting Intervention for Latino Families2R44HD071654-02 | CARAWAY, NELLDOMENECH RODRIGUEZ, MELANIE MARIE | IRIS MEDIA, INC., OR | $652,361 | ZRG1 |
| 2014 | Noninvasive Total Hemoglobin Monitor2R44HL106860-02A1 | POLOGE, JONAS ALEXANDER | KESTREL LABS, INC., CO | $651,389 | ZRG1 |
| 2014 | Instrumentation enabling a 16-fold decrease in oligonucleotide cost2R44HG006811-02 | ANDERSON, KEITH | SYNTHOMICS, INC., CA | $648,950 | ZRG1 |
| 2014 | Minimally Invasive High Intensity Ultrasound Treatment of Uterine Fibroids2R44CA121740-02 | BURDETTE, EVERETTE CDIEDERICH, CHRIS JOHN | ACOUSTIC MEDSYSTEMS, INC., IL | $647,919 | ZRG1 |
| 2014 | Tactile Text and Graphics Printer2R44AG034739-02A1 | CHEPAITIS, ANDREW J | ELIA LIFE TECHNOLOGY, INC., NY | $634,203 | ZRG1 |
| 2014 | Compact Adaptive Optics Clinical Prototype for Retinal Imaging2R44EY018509-04 | MUJAT, MIRCEA | PHYSICAL SCIENCES, INC, MA | $626,954 | ZRG1 |
| 2014 | Engineering of Human Corneal Endothelial Grafts2R44EY022502-02 | ZHU, YING TING | TISSUETECH, INC., FL | $618,105 | ZRG1 |
| 2014 | LIVERCHIP - A diagnostic tool for genetic liver diseases2R44DK093214-02 · under PA-13-088 | ZEMLAN, FRANK | P2D, INC., OH | $617,897 | ZRG1 |
| 2014 | Production of Activated TDP-Deoxysugars in E. coli2R44GM100638-02A1 | SHEPHERD, MICAH | ZUCHEM, INC., IL | $617,605 | ZRG1 |
| 2014 | Development of novel agents for the treatment of renal fibrosis2R44DK092005-02A1 | KARIHALOO, ANIL KTUCCI, FABIO COHEN | EPIGEN BIOSCIENCES, INC., CA | $616,326 | ZRG1 |
| 2014 | Biological vector control reducing arboviruses, including Dengue and Chikungunya2R44AI098179-02 · under PA-13-088 | MAINS, JAMES WILLIAM | MOSQUITOMATE, INC., KY | $610,708 | ZRG1 |
| 2014 | ZircLight: Spectrum-specific lighting for shift work2R44HL110769-02 · under PA-13-088 | HEITMANN, ANNEKEMOORE-EDE, MARTIN | CIRCADIAN MANAGEMENT, INC., MA | $609,677 | ZRG1 |
| 2014 | Fathering Through Change: Online Parent Training for Divorced Fathers (FTC)2R44HD075499-02 | CARAWAY, NELLDEGARMO, DAVID S. | IRIS MEDIA, INC., OR | $606,372 | ZRG1 |
| 2014 | Engineering Escherichia coli for sialylation of therapeutic proteins2R44GM093483-02 · under PA-13-088 | MERRITT, JUDITH H | GLYCOBIA, INC., NY | $602,221 | ZRG1 |
| 2014 | A Practical Tool for Managing the Complexity of Biologics Process Manufacturing2R44TR000187-02 | PEKNY, JOSEPH F | ADVANCED PROCESS COMBINATORICS, INC., IN | $599,724 | ZRG1 |
| 2014 | Novel IL-15 Superagonist Therapy for Bladder Cancer2R44CA156740-02 | WONG, HING C. | ALTOR BIOSCIENCE. LLC, FL | $598,323 | ZRG1 |
| 2014 | Development of a WNT Inhibitor for Advanced Stage Lung Cancer2R44CA171489-02 | ORTON, DARREN | STEMSYNERGY THERAPEUTICS, INC., FL | $592,630 | ZRG1 |
| 2014 | A rapid response detector system for intensity modulated proton therapy dosimetry2R44CA162664-02A1 | SOLBERG, KEITH A | PHENIX MEDICAL, LLC, IN | $586,795 | ZRG1 |
| 2014 | Integration of Genomic Biomarkers with the devTOX Human Embryonic Stem Cells Scre2R44ES022114-02 · under PA-13-088 | RECIO, LESLIE | INTEGRATED LABORATORY SYSTEMS, LLC, NC | $573,697 | ZRG1 |
| 2014 | A Music-Based Rehabilitation Device for Training and Assessing Hand Function2R44HD074331-02 · under PA-13-088 | FRIEDMAN, NIZAN | FLINT REHABILITATION DEVICES, CA | $568,583 | MRS |
| 2014 | Hyperquenching Cryocooler for Biomolecular X-ray Crystallography2R44GM101817-02 | NEWMAN, ROBERT | MITEGEN, LLC, NY | $564,760 | ZRG1 |
| 2014 | A Microneedle Array System for Transcutaneous Nerve Mapping2R44NS065545-03A1 · under PA-13-088 | ROSS, JAMES | AXION BIOSYSTEMS, LLC, GA | $554,886 | ZRG1 |
| 2014 | Allergens and Induced Asthma: Eradicating Indoor Allergens from Dust Mites (Phase2R44ES019790-02 · under PA-12-088 | QUICK, ALLAN M. | CARBONIX, LLC, SC | $552,991 | ZRG1 |
| 2014 | Single Therapy for Wet AMD & Geographic Atrophy1R44EY024809-01 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $548,724 | ZRG1 |
| 2014 | iNeuron: A contemporary platform for neuroscience education2R44MH096674-03 · under PA-13-088 | DUBINSKY, JANET MMICHALOWSKI, MARTIN | ADVENTIUM ENTERPRISES, MN | $539,313 | ZRG1 |
| 2014 | Fast-Switching, High-Contrast, Electrochromic Sunwear for Persons with Age-Relate2R44AG039897-02 · under PA-12-088 | CHANDRASEKHAR, PRASANNA | ASHWIN-USHAS CORPORATION, INC., NJ | $536,295 | ZRG1 |
| 2014 | Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Pr2R44NS076167-02A1 · under PA-13-088 | DAS, CHAMPAK | SFC FLUIDICS, LLC, AR | $532,640 | ZRG1 |
| 2014 | Low Cost Head Impact Alert System for Helmeted Sports2R44HD061224-04 | CHU, JEFFREY J.GREENWALD, RICHARD M | SIMBEX, LLC, NH | $531,846 | ZRG1 |
| 2014 | Saliva Analyzer for Diagnosing SRD Patient Drug Use2R44DA032178-02 | FARQUHARSON, STUART | REAL-TIME ANALYZERS, INC., CT | $530,679 | ZRG1 |
| 2014 | Low-cost Personal Sampling Pump1R43OH010635-01 | MILLER-LIONBERG, DANIEL D | ACCESS SENSOR TECHNOLOGIES, LLC, CO | $520,322 | ZRG1 |
| 2014 | Rapid and On-site Monitoring of Urinary Arsenic Metabolites2R44ES022313-02 | DWEIK, BADAWI M | GINER, INC., MA | $510,498 | ZRG1 |
| 2014 | Cheap and fast ambient air monitoring of pesticides2R44ES022539-02 | QUERALTO-GRATACOS, NURIA | ISENSE, LLC, FL | $510,400 | ZRG1 |
| 2014 | Development, Production and Testing of VLP based Respiratory Syncytial Virus (RSV1R43AI108099-01A1 · under PA-13-088 | GALARZA, JOSE M. | TECHNOVAX, INC., NY | $509,623 | ZRG1 |
| 2014 | Powered Walk/Run Prosthetic Ankle2R44HD072402-02 | HOLGATE, MATTHEW | SPRINGACTIVE, INC., AZ | $508,787 | ZRG1 |
| 2014 | Improved Noise Attenuation Foam for In the Ear Hearing and Noise Devices2R44DC011707-02A1 · under PA-13-088 | OLIVEIRA, ROBERT JAMESPARISH, WILLIAM | HEARING COMPONENTS, INC., MN | $507,182 | ZRG1 |
| 2014 | Bone Conduction Testing for Newborn Hearing Screening2R44DC011432-02A1 | DELGADO, RAFAEL E | INTELLIGENT HEARING SYSTEMS, FL | $502,379 | ZRG1 |
| 2014 | Distance Bounded Impulse Radio for Continuous Glucose Sensor2R44DK096810-02 | SEIFERT, GREGORY JOHN | ADVANCED MEDICAL ELECTRONICS CORPORATION, MN | $501,745 | ZRG1 |
| 2014 | Novel Modulators of LDL Metabolism2R44HL096167-02A1 · under PA-13-088 | ELSHOURBAGY, NABIL A | SHIFA BIOMEDICAL CORPORATION, PA | $500,000 | ZRG1 |
| 2014 | Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging2R44AT006296-03A1 | LANG-ANDERSON, ELVIRA VALENTINA | HYPNALGESICS, LLC, MA | $499,997 | ZRG1 |
| 2014 | Multifunction High Throughput System for Neurophysiology of Behavior2R44AA020676-03A1 | WOODWARD, DONALD JAY | BIOGRAPHICS, INC., NC | $499,900 | ZRG1 |
| 2014 | The Drugged Driving Resources Website for the prevention of drugged driving2R44DA038410-02 | STELTER, REBECCA LYNN | INNOVATION RESEARCH AND TRAINING, INC., NC | $497,752 | ZRG1 |
| 2014 | Device for Measuring Capillary Blood Flow and the Onset of Shock2R44HL106851-02 · under PA-13-088 | CHRISTIAN, JAMES F | RADIATION MONITORING DEVICES, INC., MA | $497,445 | ZRG1 |
| 2014 | Individualized Training and Practice in Research Career Navigation Skills2R44TR000256-02 | DEROSIER, MELISSA E.KUPFER, DAVID J | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $495,224 | ZRG1 |
| 2014 | Automated Large and Mid Scale Nucleic Acid Preparation2R44GM100580-02 · under PA-13-088 | MACCONNELL, WILLIAM P | MACCONNELL RESEARCH CORPORATION, CA | $492,521 | ZRG1 |
| 2014 | A NEW METHOD FOR THE ANALYSIS OF VITAMIN D2R44GM097798-02 | REGNIER, FRED E | NOVILYTIC, LLC, IN | $489,940 | ZRG1 |
| 2014 | Direct RT-PCR detection of RNA pathogens in crude samples2R44GM088948-02A1 | ZHANG, ZHIAN | DNA POLYMERASE TECHNOLOGY, INC., MO | $482,323 | ZRG1 |
| 2014 | Group housing: A robotic system to track and interact with individuals2R44MH098595-02 | JOHNSON, DAVID A | PINNACLE TECHNOLOGY, INC, KS | $480,369 | ZRG1 |
| 2014 | Efficient double hybrid density functional theory algorithms for conformational a2R44GM096678-02 | SHAO, YIHAN | Q-CHEM, INC., CA | $480,179 | ZRG1 |
| 2014 | CyanoMap: Mapping inland lake quality and Amyotrophic lateral sclerosis risk fact2R44ES022103-02 | TORBICK, NATHAN | APPLIED GEOSOLUTIONS, LLC, NH | $474,294 | ZRG1 |
| 2014 | A Biomimetic Prehensile Digit for Upper-Limb Amputees2R44HD070514-02A1 | VEATCH, BRADLEY D | INVISIBLE HAND ENTERPRISES, LLC, CO | $474,211 | MRS |
| 2014 | Preclinical and Clinical Evaluation of Humanized NM94051R44HL122028-01 · under PA-13-088 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $467,832 | ZRG1 |
| 2014 | End-of-Service Life Indicator (ESLI)2R44OH009341-02A1 | SRINIVAS, GIRISH | TDA RESEARCH, INC., CO | $467,567 | ZRG1 |
| 2014 | Improving MPS I ERT Efficacy through Lectin-Mediated Delivery1R43NS086326-01 · under PA-13-088 | CRAMER, CAROLE L.RADIN, DAVID | BIOSTRATEGIES, LC, AR | $458,316 | ZRG1 |
| 2014 | Elementary School Mindfulness-Based Substance Use Prevention Program2R44AA021342-02A1 · under PA-13-088 | PARKER, ALISON ELAINE | INNOVATION RESEARCH AND TRAINING, INC., NC | $457,921 | ZRG1 |
| 2014 | Point-of-Care Tests for Blood Lead Levels in Children2R44HD077971-02 | HENKENS, ROBERT W | ALDERON BIOSCIENCES, INC., NC | $453,545 | ZRG1 |
| 2014 | Destroying the HIV-1 provirus by utilizing components of the CRISPR/Cas system1R43AI110285-01 · under PA-13-088 | FANGER, MICHAEL W | CELDARA MEDICAL, LLC, NH | $451,598 | ZRG1 |
| 2014 | New Approach to Phospholipidosis Prediction2R44FD004052-02 | RZEPECKI, PIOTR W | ECHELON BIOSCIENCES, INC., UT | $449,426 | ZRG1 |
| 2014 | Identification of novel broad-spectrum Dengue antivirals1R43AI104106-01 · under PA-12-088 | HENKEL, GREGORY WILLIAM | ARISAN THERAPEUTICS, INC., CA | $449,400 | ZRG1 |
| 2014 | Electronic Alcohol Screening and Intervention in Work Settings1R44AA022570-01 · under PA-12-088 | BENNETT, JOEL B | ORGANIZATIONAL WELLNESS & LEARNING SYS, TX | $448,478 | ZRG1 |
| 2014 | Small blood pumps for small patients1R44HL118907-01A1 · under PA-13-088 | SNYDER, TREVOR ARNOULTWEARDEN, PETER D | VADOVATIONS, INC., OK | $445,050 | ZRG1 |
| 2014 | RAPID FIELD TEST FOR IODINE LEVELS IN SALT2R44HD069159-02 | VAIDYA, BIKAS | LYNNTECH, INC., TX | $444,606 | ZRG1 |
| 2014 | 2'-Fluorophosphophloretin (2FP)in the Treatment of Chronic Renal Failure2R44DK097997-02 | PEERCE, BRIAN EDWARD | DUOPHOS, LLC, TX | $432,425 | ZRG1 |
| 2014 | Caregiver SmartTools - Improving Medication Management for the Elderly2R44AG041540-02A1 · under PA-13-088 | DEITZ, DIANE K. | ISA ASSOCIATES, INC., VA | $420,040 | ZRG1 |
| 2014 | XHA-A Novel Tolerance Therapeutic for Allergic Rhinitis1R43AI104104-01A1 · under PA-13-088 | FANGER, NEIL A | VIRTICI, LLC, WA | $417,336 | ZRG1 |
| 2014 | Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Referral2R44AA021053-02 | MCPHERSON, TRACY LSCHROEDER, SUSAN WELLS | OREGON CENTER FOR APPLIED SCIENCE, INC., AZ | $410,768 | ZRG1 |
| 2014 | Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help2R44AT006952-02 | LEVIN, CRISSALEVIN, MICHAELPISTORELLO, JACQUELINE | CONTEXTUAL CHANGE, LLC, NV | $389,653 | ZRG1 |
| 2014 | Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Viru1R43AI104007-01A1 · under PA-12-088 | JOHNSTON, BRIAN H. | SOMAGENICS, INC., CA | $389,582 | ZRG1 |
| 2014 | Mitigation of Reperfusion Injury During CPR to Improve Cerebral Recovery1R43HL123194-01 | LURIE, KEITHYANNOPOULOS, DEMETRIS | RESQSYSTEMS, INC., MN | $387,465 | ZRG1 |
| 2014 | Modeling disease in swine by transplantation of gene targeted germ cells.1R43GM108150-01A1 | CARLSON, DANIEL FREDFAHRENKRUG, SCOTT CHRISTOPHER | RECOMBINETICS, INC., MN | $375,429 | ZRG1 |
| 2014 | Prevention of HIV/AIDS and STDs in Women over Fifty2R44AG034707-02A1 · under PA-13-088 | WEITZMAN, PATRICIA FLYNN | ENVIRONMENT AND HEALTH GROUP, INC., MA | $374,933 | ZRG1 |
| 2014 | A non-myeloablative conditioning regimen for hematopoietic stem cell transplantat1R43HL117576-01A1 · under PA-13-088 | GEIGER, HARTMUTZHENG, YI | P2D, INC., OH | $366,718 | ZRG1 |
| 2014 | SELF-NEUTRALIZING OLIGONUCLEOTIDES WITH ENHANCED CELLULAR UPTAKE1R43GM109517-01A1 | TABATADZE, DAVID R | ZATA PHARMACEUTICALS, INC., MA | $363,842 | ZRG1 |
| 2014 | Development of a fluorescence liposomal ABCG2 Multidrug Transporter assay1R43GM109505-01 · under PA-13-088 | MELCHIOR, DONALD LEE | GLSYNTHESIS, INC., MA | $363,564 | ZRG1 |
| 2014 | Mobile multifunctional tool for monitoring and management of respiratory diseases1R43HL123164-01 | XIAN, XIAOJUN | TF HEALTH CORPORATION, AZ | $350,703 | ZRG1 |
| 2014 | Nanoparticulate Coatings Enhance Ion Detection1R43GM106507-01A1 | LEWIS, ERNEST KJELL | IONWERKS, INC., TX | $350,497 | ZRG1 |
| 2014 | HT Label-Free Screening and Kinetic Analysis of Small Molecules and Biologics1R44GM109738-01 · under PA-13-088 | BROOKS, BENJAMIN DELBERTGALE, BRUCEMYSZKA, DAVID G. | CARTERRA, INC., UT | $329,750 | ZRG1 |
| 2014 | Engineered Neurotensin Fragments Targeting Neuropathic Pain1R43DE025162-01A1 · under PA-13-088 | DIX, THOMAS A. | JT PHARMACEUTICALS, INC., SC | $324,258 | ZRG1 |
| 2014 | Development of SVAD System for HF Therapy1R44HL123120-01 | SPENCE, PAUL A | SCR, INC., KY | $320,765 | ZRG1 |
| 2014 | Novel Hybrid Growth Factor for Immune Reconstitution in Sepsis1R43GM109620-01 · under PA-13-088 | WRIGHT, SUSAN C | PANORAMA RESEARCH, INC., CA | $306,520 | ZRG1 |
| 2014 | Novel technology to remove obscuring blood from fine needle aspiration biopsies1R43GM106489-01A1 · under PA-13-088 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY, LLC, NC | $304,833 | ZRG1 |
| 2014 | Developing the Dietary Inflammatory Index for Clinical Application1R44DK103377-01 | SHIVAPPA, NITINWIRTH, MICHAEL DAVID | CONNECTING HEALTH INNOVATIONS, LLC, SC | $304,339 | ZRG1 |
| 2014 | FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING1R43HL123196-01 | MERCHANT, MARIA | SOMNARUS, INC., CA | $303,682 | ZRG1 |
| 2014 | A novel broad-spectrum influenza vaccine1R43AI108072-01A1 · under PA-13-088 | NI, YAWEI | KJ BIOSCIENCES, LLC, TX | $300,258 | ZRG1 |
| 2014 | Innate Defense Regulator Peptide as a Therapeutic for Acute Pneumonic Melioidosis1R43AI108175-01A1 | SCHABER, CHRISTOPHER JOSEPH | SOLIGENIX, INC., NJ | $300,000 | ZRG1 |
| 2014 | Increasing viability of lung organs for transplantation1R43AI109892-01A1 | SHENG, ZELIN | TRIM-EDICINE, INC., OH | $300,000 | ZRG1 |
| 2014 | An Ultra-Stable Insulin Analog with Intrinsic Basal-Bolus Action1R43DK103445-01 | FRANK, BRUCE HILL | THERMALIN DIABETES, LLC, OH | $300,000 | ZRG1 |
| 2014 | Antifungal Compound Discovery from Metagenomes1R43AI100383-01A1 · under PA-13-088 | LI, XING-CONGLILES, MARK RMEAD, DAVID ALAN | LUCIGEN CORPORATION, WI | $298,997 | ZRG1 |
| 2014 | Identification of Novel Small Molecule AMPK Modulators1R43DK101229-01A1 | MUSSO, DAVEONYENWOKE, ROB U | CURL BIO, LLC, NC | $297,399 | ZRG1 |
| 2014 | Array Tomography Visualization and Analysis Software2R44MH096671-02A1 | LENZI, DAVID PETER | ARATOME, LLC, CA | $296,384 | ZRG1 |
| 2014 | Small molecule neuronal autophagy inducers designed to block neurodegeneration to1R43NS084567-01A1 | FINKBEINER, STEVEN MGREENHOUSE, ROBERT | NANOSYN, INC., CA | $295,299 | ZRG1 |
| 2014 | BREATHE FREE: Smartphone Videogame-Based Incentives for Smoking Cessation1R44DA036252-01 · under PA-12-088 | RAIFF, BETHANY RRAPOZA, DARION | ENTERTAINMENT SCIENCE PLAYMATICS, JV, NC | $294,464 | ZRG1 |
| 2014 | Subcutaneous Drug Development for Portal Hypertension Ascites1R43DK103553-01 | CASTILLO, GERARDO M. | PHARMAIN CORPORATION, WA | $293,272 | ZRG1 |
| 2014 | Epigenetics Probes: Production of histone modifying enzymes and identification o1R43TR000940-01A1 | MA, HAICHING | REACTION BIOLOGY CORPORATION, PA | $287,650 | ZRG1 |
| 2014 | Affinity Capture Peptides for Clinical Mass Spectrometric Assays in Plasma1R43GM112322-01 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY, LLC, NC | $283,799 | ZRG1 |
| 2014 | Novel Small Molecule Multi-targeted Ligands as Therapeutics for the Treatment of1R43NS083116-01A1 · under PA-13-088 | SINGH, JASBIR | JASIN DISCOVERY SOLUTIONS, INC., IL | $282,975 | ZRG1 |
| 2014 | Development of an iPSC-derived human hepatocyte platform for drug development.1R44GM109539-01 · under PA-13-088 | WAMHOFF, BRIAN ROBERT | HEMOSHEAR THERAPEUTICS, LLC, VA | $281,942 | ZRG1 |
| 2014 | Peptide-mediated apheresis for inflammatory bowel diseases1R43DK102243-01 | DARBY, MARTYN | AFFINERGY, LLC, NC | $280,768 | ZRG1 |
| 2014 | Peptide-mediated attachment of non-plateable hepatocytes to surfaces1R43DK103459-01 | LAMB, BRUCE | AFFINERGY, LLC, NC | $280,547 | ZRG1 |
| 2014 | Target Identification of Proteins and Peptides Capable of Recruitment of Brown Ad1R43DK101205-01 · under PA-13-088 | BOSS, OLIVIER | ENERGESIS PHARMACEUTICALS, INC., MA | $276,203 | ZRG1 |
| 2014 | Development of a novel clinical assay for measuring serum hepcidin levels1R43DK101264-01 · under PA-13-088 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY ,INC, NC | $276,193 | ZRG1 |
| 2014 | Rapid Histone Methyltransferase Profiling with Luminescent Reporters1R43GM109726-01 · under PA-13-088 | ZUTSHI, REENA | LUCEOME BIOTECHNOLOGIES, LLC, AZ | $274,561 | ZRG1 |
| 2014 | FLEXIBLE ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING IN CHILDREN1R43HL124809-01 | MERCHANT, MARIA | SOMNARUS, INC., CA | $271,961 | ZRG1 |
| 2014 | A method for preparing unbiased miRNA sequencing libraries1R43HG007788-01A1 | KAZAKOV, SERGEI A | SOMAGENICS, INC., CA | $269,378 | ZRG1 |
Showing the 200 most recent of 633 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.